Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,799 | -18,370 | -1,365 | -18,037 | -6,719 |
| Depreciation Amortization | 98 | 7,040 | 68 | 25 | 155 |
| Income taxes - deferred | 333 | -437 | -1,056 | -365 | N/A |
| Accounts payable and accrued liabilities | 568 | -276 | -1,664 | N/A | N/A |
| Other Working Capital | 994 | -277 | -2,328 | 1,311 | 618 |
| Other Operating Activity | -52 | 1,547 | -5,988 | 6,297 | 761 |
| Operating Cash Flow | $-9,858 | $-10,773 | $-12,332 | $-10,768 | $-5,185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 10,000 | N/A | 2,500 |
| PPE Investments | N/A | N/A | -448 | -2 | -40 |
| Other Investing Activity | 0 | 0 | -10,000 | 8,501 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-448 | $8,498 | $2,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,880 | 2,402 |
| Debt Repayment | N/A | -550 | -1,880 | N/A | N/A |
| Common Stock Issued | 16,207 | 10,846 | N/A | N/A | N/A |
| Other Financing Activity | -163 | -429 | 22,004 | -54 | -15 |
| Financing Cash Flow | $16,045 | $9,868 | $20,124 | $1,826 | $2,386 |
| Beginning Cash Position | 7,991 | 8,897 | 1,553 | 1,997 | 2,337 |
| End Cash Position | 14,177 | 7,991 | 8,897 | 1,553 | 1,997 |
| Net Cash Flow | $6,186 | $-905 | $7,344 | $-444 | $-339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,858 | -10,773 | -12,332 | -10,768 | -5,185 |
| Capital Expenditure | N/A | N/A | -448 | -2 | -40 |
| Free Cash Flow | -9,858 | -10,773 | -12,780 | -10,771 | -5,226 |